September 5, 2026
SOHO Insider Hem/Onc Library Lymphoma Indolent B-Cell Lymphomas

Indolent B-Cell Lymphomas

hospital bed
Lymphoma Indolent B-Cell Lymphomas News

Mosunetuzumab plus response-adapted polatuzumab vedotin, obinutuzumab shows promise as chemotherapy-free option for indolent B-cell non-Hodgkin lymphoma

Cellular Therapy Leukemia Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas News

Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL

European Commission
Lymphoma Indolent B-Cell Lymphomas

EC grants marketing authorization to epcoritamab combo in second-line FL

FDA laptop
Lymphoma Indolent B-Cell Lymphomas Mantle Cell Lymphoma News

FDA grants orphan drug designation to EO2463 to treat indolent non-Hodgkin lymphoma

keyboard
Lymphoma Indolent B-Cell Lymphomas

No OS benefit to adding bendamustine to rituximab for marginal zone lymphoma

Indolent B-Cell Lymphomas News

5-year BRUIN data show pirtobrutinib induces response in previously treated Waldenström macroglobulinemia

SOHO 2026 Trending now Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma News Society Updates

Submit an abstract for SOHO 2026 by May 15

Online news on a smart phone. Businessman reading news or article on a mobile phone screen app. Hand holding smart device. Newspaper and portal on internet. Displayed news are not reality related.
Lymphoma Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas

FDA withdraws accelerated approval of selinexor in DLBCL

FDA Green light
Lymphoma Indolent B-Cell Lymphomas News

Australia TGA approves tafasitamab combo in relapsed, refractory FL

Community Oncology News Trending now Lymphoma Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Video Interviews

Watch: Dr. Krish Patel on building partnerships between community and academic centers